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Depression is a psychiatric disorder characterized by decreased mood and affects 
daily activities. The development of herbal ingredients as complementary therapy 
becomes increasing in line with the number of patients who avoid side effects in 
conventional treatment. The purpose of this study is to investigate the potential 
effects of ethanolic extract of Ocimum sanctum L. as an antidepressant as well as 
evaluate the potential mechanism of action in the monoaminergic system in in vivo 
study. For evaluation of mechanisms of action, mice were treated serotonin 
synthesis inhibitors (pCPA), non-selective dopamine antagonists (Haloperidol) and 
selective antagonists D2 dopamine (Sulpiride) as pre-treatment. The Tail 
Suspension Test (TST) method is used as a standardized test that has generally been 
used to evaluate the antidepressant effects of a drug compound. The results showed 
that the ethanolic extract of Ocimum sanctum L. has antidepressant effect at the 
dose of 150 mg/kg. Ethanol extract of Ocimum sanctum L. was able to decrease the 
immobility time in TST mice model significantly when given pre-treatment with 
pCPA (p<0.05) and haloperidol (p<0.05), while sulpiride (p<0.05) inhibits the 
antidepressant effects of ethanolic extract of Ocimum sanctum L. significantly. 
These results showed that the monoaminergic system especially serotonergic and 
dopaminergic were involved in the antidepressant-like effects of ethanolic extract 
of Ocimum sanctum L. by involving dopamine receptors and has a role in serotonin 
synthesis.  
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BACKGROUND 
Depression is a phychiatric 
disorder that affecting mood and 
behavior in human. More than 264 
million people in the world were 
affected by this condition (WHO, 
2019). According to Riskesdas in 
2018, the prevalence of depression 
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was showed 6,1% in Indonesia, while 
the prevalence in East Java was 4.5% 
(Riskedas, 2018). Several drugs 
including selective serotonin reuptake 
inhibitors (SSRIs), serotonin & 
norepinephrine reuptake inhibitors 
(SNRIs), tricyclic antidepressants 
(TCAs) and monoamine oxidase 
inhibitors (MAOIs) were approved as 
a standard pharmacological treatment 
of depression (Katzung, 2012). 
However, about only 50% patients 
provide complete remission and 
produces more side effects after taking 
these medications. Therefore, the 
research to find alternatives or 
complementary drugs to treat 
depression and also provide more 
minimal side effects are needed, 
especially from traditional herbs. 
Ocimum sanctum L, which 
called as Kemangi, is one of 
Indonesian herbs that has potential as 
antidepressant. A study showed that 
the leaves extract of Ocimum sanctum 
L. produced significant antidepressant 
effect in animal model of depression 
(Chatterjee, 2011). Eugenol and 
apigenin were active substance that 
thought to be responsible mediating 
this effect (Bhattacharyya & Bishayee, 
2013). Eugenol compounds exhibit 
antidepressant activity by molecular 
docking (Tao et al., 2005) while 
Apigenin content also showed 
antidepressant effects by significantly 
reducing the duration of immobility 
using the Forced Swimming Test 
(FST) method (Guan, 2016). 
However, the mechanism of action of 
Ocimum sanctum L. as antidepressant 
is not fully established.  
According to monoamine 
theory, depressive symptoms are 
caused by functional deficiencies of 
monoamine neurotransmitters, such as 
serotonin (5-HT), dopamine (DA) and 
norepinephrine (NE) in the central 
nervous system (Cito et al., 2014). 
Serotonergic system involves the 
synthesis of serotonin from tryptophan 
as a precursor catalyze by the enzyme 
hydroxylase tryptophan which 
produces 5-hydroxytriptofan (5-HT) 
(Herawati, 2008). Decreased synthesis 
of serotonin is one of the factors that 
contribute on decreasing the activity of 
serotonorgic system. Furthermore, 
decreased neurotransmission of the 
dopaminergic system in the central 
nervous system causes physiological 
changes by reducing the transmission 
Jurnal Ilmiah Ibnu Sina, 6(1), Maret 2021, 143-150 
p-ISSN: 2502-647X; e-ISSN: 2503-1902  
Ridho Islamie, dkk | 145 
of DA signals (Dunlop, 2007). 
Additionally, by blocking the 
dopamine receptors was also reduced 
the dopaminergic activity which leads 
to cognitive, psychomotor and 
physiological impairments. 
This study was aimed to 
investigate the possible mechanism of 
action in  the antidepressant-like effect 
of the ethanolic extract of Ocimum 
sanctum leaves (OCE). The 
involvement of dopamine receptors 
interaction and serotonin synthesis as 
the potential mechanism of action 
were evaluated by in vivo study using 
Tail Suspension Test method as the 




The ethanolic extract of Ocimum 
sanctum L. (OCE) was purchased 
from Materia Medika Indonesia 
(Malang, East Java). The preparation 
of the extract was made using 
maceration method with ethanol 70% 
(v/v) as the solvent. Sulpiride 
(Dogmatil®) and Haloperidol was 
purchased from Apotek UBAYA with 
official permission for research 
experiments. pCPA was purchased 
from Sigma, Aldrich. 
Animals 
Male Balb-c mice (25-30 g) 
were used as experimental animal 
which kept in a 12:12-hour light-dark 
cycle. All experiments were carried 
out at temperatures 25±2°C and 
relative humidity 75±5% with access 
to food and water ad libitum. The 
habituation phase was carried out for 
seven days before the tail suspension 
test. The experiment was carried out in 
the light phase between 9.00 a.m – 
15.00 p.m. The number of animals per 
group was calculated using the 
Federer formula. All animal 
procedures were carried out following 
guidelines for the Use of Laboratory 
Animals and UBAYA Research Ethics 
Commission for animal as 
experimental subject.  
Tail Suspension Test (TST) 
Tail suspension test is one of the 
standard methods to evaluate 
antidepressant effect of potential 
substance for depressive treatment. 
The principle of this method is to hang 
the animal’s tail vertically on a 
suspension box with adhesive tape of 
the animal's tail for 6 minutes as 
shown in Figure 1. The observed 
Jurnal Ilmiah Ibnu Sina, 6(1), Maret 2021, 143-150 
p-ISSN: 2502-647X; e-ISSN: 2503-1902  
Ridho Islamie, dkk | 146 
parameter is the duration in seconds 
(sec) when the animal does not move 
or does not attempt to escape which 
refers as immobility time. The 
duration of immobility time was 




Figure 1. Tail suspension test 
apparatus. 
 
Determination of effective dose of 
antidepressant-like effect of OCE 
In this evaluation, mice were 
divided into 4 groups (n = 5 each 
group): Control group received 
vehicle (CMC Na, p.o), OCE groups 
were divided into 3 groups which 
received the Ocimum sanctum leave 
extract by per oral (p.o) at the dose of 
50 (II), 100 (III), and 150 (IV) mg/kg 
of body weight. Thirty minutes after 
the treatment, mice were hanged in the 
TST apparatus for 6 minutes. 
Immobility time (s) was recorded at 
the last 5 minutes of observation. 
Determination of the involvement of 
monoaminergic systems in the 
antidepressant-like effect of OCE 
In this test, mice were divided 
into 8 groups (n = 6 each group): 
Vehicle (CMC Na (i.p) + vehicle 
(CMC Na (p.o) as control group; 
Vehicle (CMC Na, i.p) + OCE (150 
mg/kg, p.o) as OCE group; para-
Chlorophenylalanine (100 mg/kg, i.p) 
+ Vehicle (CMC Na, p.o) as pCPA 
group; Supiride (50 mg/kg, i.p) + 
Vehicle (CMC Na, p.o) as SPD group; 
Haloperidol (0.2 mg/kg, i.p) + Vehicle 
(CMC Na, p.o), as HPL group; para-
Chlorophenylalanine (100 mg/kg, i.p) 
+ OCE (150 mg/kg, p.o); Supiride (50 
mg/kg, i.p) + OCE (150 mg/kg, p.o); 
Haloperidol (0.2 mg/kg, i.p) + OCE 
(150 mg/kg, p.o). 
The interval time between first 
and second treatment was 30 minutes. 
mice were then hanged in the TST 
apparatus for 6 minutes after 30 
minutes of the second treatment. 
Immobility time (s) was recorded at 
the last 5 minutes of observation. 
Data Analysis 
All data were presented as mean 
± standard deviation (SD). The data 
obtained was statistically tested using 
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One-Way ANOVA followed by 
Tukey's test for multiple comparison. 
Statistics analysis was performed 
using Graph Pad Prism software 
version 9.0. The statistics significance 
was defined if the p-value < 0.05. 
 
RESULTS AND DISCUSSION 
 
Figure 2. Effect of OCE in TST in 
mice. *** p < 0.001 compared with 
control group.  
 
Before the evaluation of 
possible mechanisms of action in the 
monoaminergic system, the effective 
dose determination of OCE as an 
antidepressant in the animal model 
TST was performed. As shown in 
Figure 2., one-way ANOVA analysis 
showed that OCE was able to 
significantly lower immobility time 
(***p<0.001) compared to the control 
group at a dose of 150 mg/kg, while at 
doses of 50 and 100 mg/kg there was 
no significant difference between the 
OCE group and the control group. 
These results revealed that Ocimum 
sanctum L. leaf extract obtained by 
maceration with ethanol 70% can 
produce antidepressant-like effect on 
TST model in mice. 
Results in Figure 3. indicate the 
possible mechanism of action in 
antidepressants-like effect of OCE in 
serotonin synthesis. In this study, 
pCPA, a serotonin synthesis inhibitor, 
was used to investigate the 
involvement of the serotonergic 
system on the mechanism of action of 
OCE as an antidepressant. According 
to one-way ANOVA analysis, pCPA 
significantly (*p<0.05) increased 
immobility time compared to the 
control group on the TST model in 
mice. This indicates that pCPA 
successfully induces the effects of 
depression through inhibition of 
serotonin synthesis. Then, pCPA + 
OCE group also showed significant 
differences (#p<0.05) to the pCPA 
group where OCE can decrease the 
effects of depression induced by 
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antidepressant-like effect of OCE 
contribute to the synthesis of 
serotonin. The mechanism of action of 
conventional antidepressant drugs is 
generally based on increased 
bioavailability of serotonin in the 
brain (Brunello et al., 2002). 
 
 
Figure 3. Antidepressant-like effect 
of OCE involved in serotonin 
synthesis in TST mice model. 
*p<0.05, *** p < 0.001 compared 
with control group, # p <0.05 
compared with pCPA group. 
 
The results from Figure 4. and 5. 
were showed the involvement of 
dopaminergic system in the 
antidepressant-like effect of OCE in 
TST model in mice. In this study, 
haloperidol (non-selective dopamine 
antagonist) and sulpiride (selective 
dopamine D2 antagonist) were used as 
the pre-treatment to investigate the 
contribution of dopaminergic system. 
As shown in Figure 4., the inhibition 
of dopamine activity by haloperidol 
increased immobility time 
significantly (**p<0.01) compared 
with control group. Then, OCE can 
also significantly (#p<0.05) reduced 
depression-like effect produced by 
haloperidol. This result indicates that 
OCE could be interact with dopamine 
receptor especially on D1 receptor. 
   
 
Figure 4. Antidepressant-like effect 
of OCE involved in D1 receptor 
interaction in TST mice model. 
*p<0.05, **p<0.01, *** p < 0.001 
compared with control group. 
#p<0.05 compared with HPL group. 
 
Figure 5. shows that the 
antidepressant-like effect of OCE was 
mediated by D2 receptor modulation. 
As we know that OCE alone treated 
group produced antidepressant-like 
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reduced the immobility time compare 
to control group. However, the 
immobility time between SPD group 
and SPD + OCE group also differs 
significantly (#p<0.05) where the 
immobility time of SPD + OCE group 
was higher than SPD treated group. 
Therefore, the pre-treatment with 
sulpiride inhibits antidepressant-like 
effect produced by OCE. This result 
indicates that OCE could be interact 




Figure 5. Antidepressant-like effect 
of OCE involved in D2 receptor 
modulation in TST mice model. *** p 
< 0.001 compared with control group, 
#p<0.05 compared with SPD group. 
 
Several studies have shown that 
the effects of antidepressants through 
modulation on the dopaminergic 
system are effective for the treatment 
of depression (D'Aquila et al., 2000; 
Willner et al., 2005). In addition, 
antagonist agent D1 and D2 receptors 
can inhibit the antidepressant effects 
of some agents on FST and TST 
models (Machado et al., 2007). 
Clinical studies also show that D2 
receptor agonists are effective for the 
treatment of depressed patients 
(Waehrens and Gerlach, 1981).  
 
CONCLUSION 
In conclusion, the present study 
demonstrated that the ethanolic leaf 
extract of Ocimum sanctum L. exhibits 
an antidepressant-like effect by 
involving its interaction with 
dopamine receptors and also plays a 
role in serotonin synthesis. Altogether, 
this finding suggest that Ocimum 
sanctum L. may have potential as 
pharmacological treatment of 
depression and its antidepressant-like 
effect mediated by serotonergic and 
dopaminergic system.  
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